Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Aktham Mestareehi"'
Autor:
Aktham Mestareehi
Publikováno v:
ACS Omega, Vol 9, Iss 24, Pp 26075-26096 (2024)
Externí odkaz:
https://doaj.org/article/5703ad236b9941458e212304eeae9805
Autor:
Aktham Mestareehi, Noor Abu-Farsakh
Publikováno v:
ACS Omega, Vol 9, Iss 9, Pp 10299-10331 (2024)
Externí odkaz:
https://doaj.org/article/d2ca4fe665714bc98b8c3dc36a839194
Autor:
Aktham Mestareehi, Xiangmin Zhang, Berhane Seyoum, Zaher Msallaty, Abdullah Mallisho, Kyle Jon Burghardt, Anjaneyulu Kowluru, Zhengping Yi
Publikováno v:
Journal of Diabetes Research, Vol 2021 (2021)
Context. Skeletal muscle insulin resistance is one of the primary contributors of type 2 diabetes (T2D). Metformin is the first-line drug for the treatment of T2D. The primary effects of metformin include decreasing glucose production in the liver an
Externí odkaz:
https://doaj.org/article/911aea2ca4744002ac182ccfe226cea7
Autor:
Aktham Mestareehi, Hainan Li, Xiangmin Zhang, Sai Pranathi Meda Venkata, Ruchi Jaiswal, Fu-Shin Yu, Zhengping Yi, Jie-Mei Wang
Publikováno v:
ACS Omega. 8:16206-16217
Autor:
Kyle J. Burghardt, Berhane Seyoum, Aktham Mestareehi, Abdullah Mallisho, Zaher Msallaty, Zhengping Yi, Anjaneyulu Kowluru, Xiangmin Zhang
Publikováno v:
Journal of Diabetes Research
Journal of Diabetes Research, Vol 2021 (2021)
Journal of Diabetes Research, Vol 2021 (2021)
Context. Skeletal muscle insulin resistance is one of the primary contributors of type 2 diabetes (T2D). Metformin is the first-line drug for the treatment of T2D. The primary effects of metformin include decreasing glucose production in the liver an
Autor:
Aktham Mestareehi, Zaher Msallaty, Abdullah Mallisho, Zhengping Yi, Xiangmin Zhang, Anjan Kowluru, Berhane Seyoum
Publikováno v:
Diabetes. 69
Skeletal muscle insulin resistance is one of the primary contributors of type 2 diabetes (T2D). Metformin is the first-line drug for the treatment of T2D. Main known effects of metformin include inhibition of glucose production in liver and attenuati
Publikováno v:
Diabetes. 69
Insulin resistance in skeletal muscle is among the primary contributors to the development of type 2 diabetes (T2D), a leading cause of heart disease, stroke, etc. Over 26 million U.S. adults have T2D. Molecular mechanisms for skeletal muscle insulin
Autor:
Xiangmin Zhang, Majed Alharbi, Abdullah Mallisho, Divyasri Damacharla, Danjun Ma, Anjaneyulu Kowluru, Abdul B. Abou-Samra, Wissam Al-Janabi, Yue Qi, Sorin Draghici, Zaher Msallaty, Rebecca Tagett, Griffin Calme, Michael Caruso, Zhengping Yi, Aktham Mestareehi, Berhane Seyoum
Publikováno v:
J Clin Endocrinol Metab
Context Obesity-related insulin resistance (OIR) is one of the main contributors to type 2 diabetes and other metabolic diseases. Protein kinases are implicated in insulin signaling and glucose metabolism. Molecular mechanisms underlying OIR involvin
Autor:
Vijayalakshmi Thamilselvan, Xiangmin Zhang, Anjaneyulu Kowluru, Divyasri Damacharla, Aktham Mestareehi, Zhengping Yi
Publikováno v:
Mol Cell Endocrinol
Rac1, a small G protein, regulates physiological insulin secretion from the pancreatic β-cell. Interestingly, Rac1 has also been implicated in the onset of metabolic dysfunction of the β-cell under the duress of hyperglycemia (HG). This study is ai